Ono Pharmaceutical Co Ltd (4528.T)
16 Aug 2019
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|60||2008||President, Representative Director|
|57||2015||Executive Vice President, Chief Director of Development, Director|
|59||2017||Senior Managing Executive Officer, Chief Director of Business Administration, Director of Product Strategy, Director|
|57||2018||Managing Executive Officer, Chief Director of Sales, Senior Director of Primary|
|59||2016||Managing Executive Officer, Chief Director of Reliability Assurance, Director|
- Nikkei flat as trade woes, strong yen saps risk appetite; SoftBank Group falls
- Nikkei hits 3-1/2-month low as carmakers plunge on Trump's Mexico tariff jolt
- Nikkei tumbles to 3-month low as carmakers plunge on Trump's Mexico tariff
- As medical costs mount, Japan to weigh cost-effectiveness in setting drug prices